Endovia Health Sciences, Inc.
EDVA- Exchange
- NYSE
- Industry
- Beverages
- SEC CIK
- 0001553788
No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Endovia Health Sciences, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- +4 vs. Q2 2021
- Shares held
- 460.0K
- +180.8K (+64.8%) vs. Q2 2021
- Total value
- $919.0K
- −$94.0K (−9.3%) vs. Q2 2021
- New holders
- 7
- 2 more added
- Sold out
- 3
- 2 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $172.1K |
| Q1 2026 | 16 | $243.9K |
| Q4 2025 | 14 | $150.7K |
| Q3 2025 | 17 | $255.7K |
| Q2 2025 | 12 | $260.9K |
| Q1 2025 | 11 | $93.4K |
| Q4 2024 | 34 | $720.8K |
| Q3 2024 | 31 | $1.04M |
| Q2 2024 | 32 | $903.3K |
| Q1 2024 | 28 | $1.37M |
| Q4 2023 | 30 | $1.40M |
| Q3 2023 | 28 | $1.61M |
| Q2 2023 | 26 | $2.93M |
| Q1 2023 | 21 | $3.45M |
| Q4 2022 | 24 | $2.19M |
| Q3 2022 | 23 | $2.83M |
| Q2 2022 | 22 | $6.81M |
| Q1 2022 | 25 | $7.96M |
| Q4 2021 | 15 | $484.0K |
| Q3 2021 | 13 | $919.0K |
| Q2 2021 | 9 | $1.01M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Endovia Health Sciences, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Parsons Capital Management Inc | 143,251 | $287.0K | 0.02% | +100,002+231.2% | Added |
| Millennium Management LLC | 118,780 | $238.0K | 0.00% | +118,780 | New |
| FNY Investment Advisers, LLC | 58,873 | $117.0K | 0.05% | −45,527−43.6% | Reduced |
| Verition Fund Management LLC | 50,000 | $100.0K | 0.00% | 00.0% | Unchanged |
| Oppenheimer & Co Inc | 23,366 | $47.0K | 0.00% | +23,366 | New |
| Jane Street Group, LLC | 22,204 | $44.0K | 0.00% | +22,204 | New |
| Northern Trust Corp | 15,763 | $32.0K | 0.00% | +15,763 | New |
| Vanguard Group Inc | 14,290 | $29.0K | 0.00% | +14,290 | New |
| Berman Capital Advisors, LLC | 7,833 | $15.0K | 0.00% | +7,833 | New |
| Morgan Stanley | 3,200 | $6.00K | 0.00% | +1,450+82.9% | Added |
| UBS Group AG | 2,189 | $4.00K | 0.00% | −2,786−56.0% | Reduced |
| Tower Research Capital LLC (TRC) | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 121 | $0 | 0.00% | +121 | New |
| Shay Capital LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −23,120−100.0% | Sold out |
| BDO Wealth Advisors, LLC | 0 | $0 | 0.00% | −1,527−100.0% | Sold out |